This Reagan-Udall Foundation for the FDA report strives to bridge the gap between technical and business teams in the ecosystem of FDA-regulated products and the nation’s food supply by building the business case for industry investment in in silico technologies as a strategic imperative for accelerating breakthroughs and market leadership in FDA-regulated products, thus transforming human health.
- About
- Projects
- Research
- Advancing FDA Mechanisms to Address Complex Cross-Sectoral Health Threats
- Addressing Unmet Need Within the Animal and Veterinary Industries
- Antimicrobial Use Data in Food Animals
- Expanded Access Navigator
- Fellowship
- Food & Nutrition
- FDA Operational Evaluation
- FDA Patient Listening Sessions
- Improving Access to Publicly Available FDA Information
- Improving Understanding of the FDA and FDA-Regulated Products
- Substance Use Disorders
- COVID-19 Hub
- Regulatory Science Accelerator
- News and Events
- eRequest
